SurgePays, Inc. (NASDAQ:SURG) Just Reported And Analysts Have Been Cutting Their Estimates
SurgePays, Inc. (NASDAQ:SURG) Just Reported And Analysts Have Been Cutting Their Estimates
There's been a major selloff in SurgePays, Inc. (NASDAQ:SURG) shares in the week since it released its quarterly report, with the stock down 21% to US$1.90. It was a pretty bad result overall; while revenues were in line with expectations at US$15m, statutory losses exploded to US$0.66 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on SurgePays after the latest results.
SurgePays, Inc.(纳斯达克代码:SURG)自上周发布季度报告以来股价大幅下跌,跌幅达21%,目前报价1.90美元。本季度业绩表现不佳,尽管营业收入为1500万美元,符合预期,但每股收益达到了0.66美元,出现了规模性亏损。分析师们已更新了财报模型,大家想知道公司前景是否发生了巨大变化,还是一切照旧。我们已经整合了最新的营收预测,想看看分析师们在最新的财报公布后有没有对SurgePays改变看法的了解的读者可以放心。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240816/0-4cc1fca8f62f7a119b991a08e30bca5d-0-e94ec5cf8310eb691c5087fd12f0b166.png/big)
Taking into account the latest results, the dual analysts covering SurgePays provided consensus estimates of US$68.6m revenue in 2024, which would reflect a concerning 39% decline over the past 12 months. The statutory loss per share is expected to greatly reduce in the near future, narrowing 1,263% to US$1.06. Before this earnings report, the analysts had been forecasting revenues of US$100.4m and earnings per share (EPS) of US$0.005 in 2024. So we can see that the consensus has become notably more bearish on SurgePays' outlook following these results, with a pretty serious reduction to next year's revenue estimates. Furthermore, they expect the business to be loss-making next year, compared to their previous calls for a profit.
综合考虑最新的数据,覆盖SurgePays公司的两位分析师提供了预计2024年6880万美元的营收的一体化预测,预计过去12个月的营收将出现39%的下滑。每股收益的规模性亏损预计将在不久的将来得到大幅削减,缩小到1.06美元,同比减少1,263%。此前,分析师们的营收预测为10040万美元,预计2024年每股收益(EPS)为0.005美元。因此,基于最新数据,我们可以看到分析师们对SurgePays的前景持更为看淡的看法,对明年的营收预期大幅减少。此外,他们预计公司明年将亏损,而不是之前的盈利预期。
The consensus price target fell 15% to US$5.75, with the analysts clearly concerned about the company following the weaker revenue and earnings outlook.
分析师对SurgePays公司的担忧明显,营收和盈利预期低迷,普遍预计其股价目标下降15美分,至5.75美元。
Of course, another way to look at these forecasts is to place them into context against the industry itself. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 63% by the end of 2024. This indicates a significant reduction from annual growth of 35% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 3.9% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - SurgePays is expected to lag the wider industry.
当然,还有一种方法可以将这些预测与整个行业相比较。这些预测表明,收入预计将出现下滑,到2024年底,年化下滑幅度预计为63%。这表明,在过去的五年中,年增长率从35%下降至目前的预测水平。相反,我们的数据表明,同一行业中的其他上市公司(有分析师跟踪)预计在可预见的未来内将年增长率为3.9%。虽然SurgePays的营收预计将缩水,但这一趋势并不会成为它的优势,相反,公司将落后于整个行业板块。
The Bottom Line
最重要的事情是分析师增加了它对下一年每股亏损的估计。令人欣慰的是,营收预测未发生重大变化,业务仍有望比整个行业增长更快。共识价格目标稳定在28.50美元,最新估计不足以对价格目标产生影响。
The biggest low-light for us was that the forecasts for SurgePays dropped from profits to a loss next year. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of SurgePays' future valuation.
对我们来说最大的问题是,SurgePays的预测从明年的盈利变为了亏损。消极的一面是,他们还下调了营收预期,并预计它们将表现比整个行业更为不佳。分析师们普遍认为此公司未来的估值有所下降。
With that in mind, we wouldn't be too quick to come to a conclusion on SurgePays. Long-term earnings power is much more important than next year's profits. At least one analyst has provided forecasts out to 2025, which can be seen for free on our platform here.
因此,我们不应急于对SurgePays作出结论。长期的盈利能力比明年的利润更加重要。有至少一位分析师提供了到2025年的预测。感兴趣的读者可以在我们的平台上免费查看。
That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 5 warning signs with SurgePays , and understanding them should be part of your investment process.
虽然如此,考虑到投资风险的普遍存在,更确保谨慎是必要的。我们已经发现了SurgePays的5个投资风险警告,了解这些警告应该成为您投资过程的一部分。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。